Symposium Highlights

New DES Directions

Bioabsorbable Polymers and Polymer-Free Stents: Theoretical Advantages and Provocative Early Results
First vs. Second Generation DES: Are There Meaningful Differences?
First Presentation of the SPIRIT IV Cost-Effectiveness Study

Adjunctive Pharmacology

Clopidogrel Resistance and Genetic Polymorphisms
Current Selection of Thienopyridines in ACS
Heparin or Bivalirudin for PCI in Stable CAD, NSTEMI, and STEMI

Adjunctive Imaging & Physiology

FFR Beyond Fame: Tips and Tricks For Optimal Use
OCT: What Are the Practical Advantages (and Disadvantages) Compared to IVUS?
Ten Cases Why You Must Use IVUS Routinely

Complex Lesion Management

AMI Intervention: The Case for DES and/or Aspiration
Borderline SVG Lesions: To Treat or Not to Treat
Left Main PCI: Selection and Strategies

 

Save the Date

March 13, 2010

Program 5:00 pm-9:10 pm

Omni Hotel at CNN Center
International Ballroom A, B, C, D
100 CNN Center
Atlanta, GA



register-button.png

Stay Up to Date

Enter your email address below to receive updates on Optimizing PCI Outcomes and other CRF educational activities: